Abbvie reported $5.02B in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US USD 4.59B 36M
Abbvie ABBV:US USD 5.02B 880M
Amgen AMGN:US USD 1.59B 78M
Astrazeneca AZN:US USD 2.12B 214M
AstraZeneca AZN:LN USD 2.12B 214M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Coherus Biosciences CHRS:US USD 35.23M 23.96M
Eisai 4523:JP JPY 45.13B 2.27B
Eli Lilly And LLY:US USD 1.58B 148.6M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Horizon Pharma HZNP:US USD 234.13M 3.92M
Infinity Pharmaceuticals INFI:US USD 429K 15K
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Johnson & Johnson JNJ:US USD 7.76B 29M
Medtronic MDT:US USD 2.48B 18M
Merk MRK:US USD 3.43B 715M
Neurocrine Biosciences NBIX:US USD 6.1M 1.3M
Novartis NOVN:VX USD 3.66B 92M
Pacira Pharmaceuticals PCRX:US USD 50.68M 51K
Perrigo Ordinary Shares PRGO:US USD 737.3M 12.3M
Pfizer PFE:US USD 6.09B 2.58B
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Revance Therapeutics RVNC:US USD 10.74M 1.21M
Roche Holding ROG:VX 9.56B 717M
Teva Pharmaceutical Industries TEVA:US USD 1.88B 73M
Ultragenyx Pharmaceutical RARE:US USD 8.63M 361K
United Therapeutics UTHR:US USD 37.2M 7.5M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M
Zoetis ZTS:US USD 606M 14M